Abstract. Depressed and flat surface lesions are not easy to identify with routine colonoscopies during screening for colorectal cancer (CRC). Identifying clinically relevant genes that influence tumor shape could be useful when screening for the presence of depressed lesions. Total RNA was extracted from tumor cells collected by laser microdissection from the primary lesions of 146 CRC cases. Microarray analysis was performed to identify genes that were differentially expressed between depressed and elevated tumors. Single nucleotide polymorphism (SNP) analysis of genomic DNA from the peripheral blood of 67 CRC patients was then used to associate polymorphisms with the occurrence of depressed tumors. Microarray analysis revealed significantly higher expression of the fibronectin 1 (FN1) gene in 129 depressed-type tumors and lesions compared to 17 elevated-type tumors. FN1-abundant CRC tumors were large with a significantly higher incidence of lymphatic permeation. SNP analysis indicated that 44 tumors with a GG genotype at SNP rs6707530 showed significantly higher FN1 expression than did 23 tumors with GT/TT genotypes (p<0.05). The product of the FN1 gene (located at 2q34) is involved in cell adhesion, migration and metastasis in mesenchymal tumors. Abundant expression of FN1 may allow cancer cells to invade deeper layers, which would eventually define tumor shape. Identification of this SNP in blood samples may facilitate disease diagnosis and allow prediction of the presence of depressed tumors in the colorectal epithelium before a colon fiberscope examination.
Introduction
The size and shape of a lesion in colorectal cancer (CRC) are believed to be connected directly to clinical phenotype and to serve as predictors of malignant behavior (1, 2) . Early superficial CRC lesions can be classified as elevated (polypoid and non-polypoid) or depressed (3, 4) . Polypoid lesions grow above the surface of the mucosa and the volume of the polypoid component appears to be correlated with malignant behavior. Non-polypoid lesions may grow flat or slightly elevated, eventually progressing, into polypoid lesions or lateral spreading tumors. Finally, depressed lesions (0-IIc, 0-IIc+IIa, 0-IIa+IIc), which comprise only 2.3% of all superficial lesions (5), warrant particular attention due to the difficulty of detection and removal by fiberscope (6, 7) . Since depressed-type lesions are frequently located in the right colon, they can be difficult to detect. Moreover, depressed lesions, independent of size, have been associated with an increased risk of rapid progression to cancer, as shown in endoscopy and pathology units in Japan (4, 5, 8, 9) . Depressed-type lesions and tumors, such as earlier phase lesions (0-IIc, 0-IIc+IIa, 0-IIa+IIc) and/or advanced tumors (types 2 and 3), invade and metastasize to lymph nodes and other distant organs and indicate a poorer prognosis than do type 1 tumors.
Microarray analysis of RNA from the cancer cells of 144 CRC cases revealed that the fibronectin 1 (FN1) gene is significantly associated with tumor shape in CRC. FN1 is a glycoprotein that is present in a soluble dimeric form in the plasma, and in a dimeric or multimeric form at the cell surface and in the extracellular matrix (10) . It is involved in cell adhesion and migration processes including embryogenesis, wound healing, blood coagulation, host defense and metastasis. The gene has 3 regions that are subject to alternative splicing, with the potential to produce 20 transcript variants. However, the full-length nature of some of these variants has not been determined.
In the present study, we performed a comprehensive analysis to identify genes that determine tumor shape (11) . Evaluation of changes in the expression patterns of these genes may allow physicians to make a precise, non-invasive diagnosis of depressed-type lesions in early CRC. Collection of CRC cells. Tissues from the 146 CRC patients were collected for LMD using the Leica Laser Microdissection System (Leica Microsystems, Wetzlar, Germany). In brief, 5-µm frozen sections were fixed in 70% ethanol for 30 sec, stained with hematoxylin and eosin and dehydrated as follows: 5 sec each in 70, 95 and 100% ethanol and a final 5 min in xylene. The sections were air-dried, then microdissected with the LMD system. Target cells, at least 100 cells/section, were excised and bound to transfer film for total DNA extraction.
Total RNA extraction and first-strand cDNA synthesis. CRC tissue specimens or cultured cell lines at subconfluency were homogenized, and total RNA was extracted using the modified acid-guanidine-phenol-chloroform method. Total RNA (8.0 µg) was reverse transcribed to cDNA using M-MLV RT (Invitrogen Corporation, Carlsbad, CA, USA).
qRT-PCR. The sequences for FN1 mRNA were: FN1, sense primer, 5'-GAACTATGATGCCGACCAGAA-3' and antisense primer, 5'-GGTTGTGCAGATTTCCTCGT-3'. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal control and GAPDH primers were: sense primer 5'-TTGGTATCGTGGAAGGACTCTA-3' and antisense primer, 5'-TGTCATATTTGGCAGGTT-3'. Real-time monitoring of PCR reactions was performed using the LightCycler system (Roche Applied Science, Indianapolis, IN, USA) and SYBR-Green I dye (Roche Diagnostics, Tokyo, Japan). Monitoring was performed according to the manufacturer's instructions. In brief, a master mixture containing 1 µl of cDNA, 2 µl of DNA Master SYBR-Green I mix, 50 ng of primers and 24 µl of 25 mM MgCl 2 was prepared on ice, and the final volume was adjusted to 20 µl with water. After the reaction mixture was loaded into glass capillary tubes, qRT-PCR was performed with the following cycling conditions: initial denaturation at 95˚C for 10 min, followed by 45 cycles of 95˚C for 10 sec, annealing at 60˚C for 10 sec and extension at 72˚C for 10 sec. After amplification, products were subjected to a temperature gradient from 65˚ to 95˚C at 0.2˚C/ sec, under continuous fluorescence monitoring, to produce a melting curve for analysis of primer specificity. 
Evaluation of representative SNPs in the FN1 coding region.
Genomic DNA was extracted from the peripheral blood of 64 patients with primary CRC using a QIAamp DNA Mini kit according to the manufacturer's protocol (Qiagen, Valencia, CA, USA). SNPs in the exonic and intronic regions of FN1 were evaluated simultaneously using an Affymetrix genome-wild SNP array to determine the association between FN1 expression and the genotype of each SNP in the FN-1 gene: rs6707530, rs11651, rs7594168, rs10498037, rs33996776, rs1250214, rs7568287, rs10201850, rs41347752, rs1250204, rs7588661, rs2577302, rs1968510, rs34255697, rs10172425, rs7572169, rs2372545, rs1250264, rs12105173, rs10199059, rs1437799, rs1250270, rs11693652, rs7567647, rs1898536, rs10202483, rs1250247, rs1250233, rs6753702 and rs1250252. However, rs2372545 and rs1250264 were excluded due to low-quality data. The Ethics Committee of each institute approved this project.
Results

Differential expression of FN-1 in cells isolated from CRC primary tumors.
Microarray analysis revealed a significant difference in the expression of the FN1 gene between depressed-type tumors and lesions (0-IIb, 0-IIc, 0-IIa+IIc, 0-IIc+IIa, type 2 and type 3 tumors) and elevated-type tumors (0-Ip, 0-Isp, 0-Is, 0-IIa and type 1 tumors). The microarray contained three probes for FN1, all of which were significantly upregulated in depressed-type lesions (n=129) compared to elevated-type tumors (n=17). The 3 probes were also used to validate these findings in representative samples of depressed (n=19) and elevated (n=9) tumors and normal tissues (n=9).
The 19 depressed tumors showed significantly higher expression than the other groups (raw p-value, 1.03985x10
; q-value, 5.17319x10 -3 ; fold-change, 32.4169; Fig. 1 ). In comparison to that of normal samples, the average expression of FN1 in depressed type lesions was upregulated, while expression in elevated-type lesions was downregulated.
qRT-PCR supported the finding that the expression of FN1 in the subgroup of depressed tumors (19 tumors; 1.47±0.36) was significantly higher (p<0.05) than that in the subgroup of elevated tumors (n=18; 0.39±0.37; Fig. 2 ).
Clinicopathological significance of FN1 in CRC cases. In addition to tumor shape, 2 other clinicopathological factors were associated with FN1 expression (Table I ). Higher expression was observed in larger tumors (>5 cm; n=71) than in smaller tumors (n=75; p=0.0024). There was also a significant difference in FN1 expression between lymphatic permeation negative (n=65; 4.38±0.24) and positive (n=61; 3.70±0.22) tumors (p=0.036).
FN1 expression is associated with 1 SNP.
Of the 30 SNPs in the FN1 region, rs6707530 was associated with tumor shape in CRC (Fig. 3) . The expression of FN1/GAPDH was higher in CRC samples with a GG genotype (n=44; 4.09±0.32) at this locus rather than a GT or TT genotype (n=23; 3.32±0.45). 
Discussion
The tumorigenesis of depressed tumors progresses along a different pathway from the conventional path for elevated tumors that was advocated by Vogelstein et al (4) . It is believed that malignant cells in serrated and adenomatous lesions proliferate and grow laterally and top-down from the surface of the lesion (1-3). However, little is known about how the molecular biology of certain cancer cells is determined. In the present study, we focused on clarifying the mechanism responsible for the differentiation of the shapes of malignant cells. In order to do this, we extracted cancer cells from primary tumor tissues, avoiding contamination with interstitial cells or non-malignant cells with the use of LMD. Microarray analysis following the extraction of total RNA and purified mRNA identified 1 gene, FN1 (10) . FN1 was more highly expressed in the interstitial tissues than in the superficial glands in the section (Fig. 4) . We propose that the abundant expression of FN1 may allow for the generation of traction forces through its surface receptors. However, further in vitro and in vivo studies are required to answer this question.
CRC characterized by depressed tumors has a higher incidence of recurrence than CRC cases characterized by elevated tumors (Fig. 5) . Considering practical clinical applications, reliable markers that can be used to predict tumor shape may facilitate the early diagnosis of malignancy prior to a colonoscopy. In the present study, we identified 1 SNP in FN1 that was significantly associated with tumor shape.
In conclusion, we found that the majority of CRC cases with depressed tumors had a higher frequency of elevated FN1 expression. In addition, we could predict the presence of depressed tumors by evaluation of 1 SNP (rs6707530) in the FN1 region in germline DNA from peripheral blood. This discovery will beneficial in the clinical setting, providing a method for the early diagnosis of depressed-type tumors by colon fiberscope.
